CRP and lobular neoplasia: Furthermore, CRP35–47 has been found to bind factor H, and antibodies targeting this region can inhibit the enhanced cofactor ability factor H achieves when bound to CRP (26), and anti-mCRP35–47 antibodies together with anti-C1qA08 antibodies are shown to associate with a worse renal prognosis in LN (27).